Prostate Cancer Therapeutic Clinical Investigation "First in Man"
Location(s): United States
Immunotherapy offers the potential to stimulate a prostate cancer patient’s immune response to kill a growing tumor. Unfortunately, cancer cells are very weak vaccine agents and require other co-therapeutic strategies to be effective. This project proposes to enhance the immune response to prostate cancer with a variety of approaches that might result in elimination of tumors.